Related references
Note: Only part of the references are listed.Novel Bioenhanced Curcumin With Mesalamine for Induction of Clinical and Endoscopic Remission in Mild-to-Moderate Ulcerative Colitis A Randomized Double-Blind Placebo-controlled Pilot Study
Rupa Banerjee et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2021)
A combination index and glycoproteomics-based approach revealed synergistic anticancer effects of curcuminoids of turmeric against prostate cancer PC3 cells
Meng-Meng Wei et al.
JOURNAL OF ETHNOPHARMACOLOGY (2021)
PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews
Melissa L. Rethlefsen et al.
SYSTEMATIC REVIEWS (2021)
Evidence-based clinical practice guidelines for inflammatory bowel disease 2020
Hiroshi Nakase et al.
JOURNAL OF GASTROENTEROLOGY (2021)
Curcumin ameliorates DSS-induced colitis in mice by regulating the Treg/Th17 signaling pathway
Cheng Wei et al.
MOLECULAR MEDICINE REPORTS (2021)
Oral Curcumin No More Effective Than Placebo in Preventing Recurrence of Crohn's Disease After Surgery in a Randomized Controlled Trial
Gilles Bommelaer et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Curcumin, as a pleiotropic agent, improves doxorubicin-induced nephrotic syndrome in rats
Hua-ying Fan et al.
JOURNAL OF ETHNOPHARMACOLOGY (2020)
The effect of curcumin supplementation on clinical outcomes and inflammatory markers in patients with ulcerative colitis
Narges Sadeghi et al.
PHYTOTHERAPY RESEARCH (2020)
Curcumin metabolites contribute to the effect of curcumin on ameliorating insulin sensitivity in high-glucose-induced insulin-resistant HepG2 cells
Pan Li et al.
JOURNAL OF ETHNOPHARMACOLOGY (2020)
Curcumin and Intestinal Inflammatory Diseases: Molecular Mechanisms of Protection
Kathryn Burge et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The Additive Effects of Low Dose Intake of Ferulic Acid, Phosphatidylserine and Curcumin, Not Alone, Improve Cognitive Function in APPswe/PS1dE9 Transgenic Mice
Hiaki Okuda et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2019)
AGA Technical Review on the Management of Mild-to-Moderate Ulcerative Colitis
Siddharth Singh et al.
GASTROENTEROLOGY (2019)
AGA Clinical Practice Guidelines on the Management of Mild-to-Moderate Ulcerative Colitis
Cynthia W. Ko et al.
GASTROENTEROLOGY (2019)
ACG Clinical Guideline: Ulcerative Colitis in Adults
David T. Rubin et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)
Curcumin nanomicelle improves semen parameters, oxidative stress, inflammatory biomarkers, and reproductive hormones in infertile men: A randomized clinical trial
Fatemeh Alizadeh et al.
PHYTOTHERAPY RESEARCH (2018)
Health-Related Quality of Life and Work-Related Outcomes for Patients With Mild-to-Moderate Ulcerative Colitis and Remission Status Following Short-Term and Long-Term Treatment With Multimatrix Mesalamine: A Prospective, Open-Label Study
Aaron Yarlas et al.
INFLAMMATORY BOWEL DISEASES (2018)
Curcumin for the Management of Periodontitis and Early ACPA-Positive Rheumatoid Arthritis: Killing Two Birds with One Stone
Eleni Asteriou et al.
NUTRIENTS (2018)
Curcumin as a therapeutic agent for blocking NF-κB activation in ulcerative colitis
Yiqing Wang et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2018)
The efficacy of curcuminoids in improvement of ulcerative colitis symptoms and patients' self-reported well-being: A randomized double-blind controlled trial
Mohsen Masoodi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Use of Curcumin in Achieving Clinical and Endoscopic Remission in Ulcerative Colitis: A Systematic Review and Meta-analysis
Umair Iqbal et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2018)
Oral Adjuvant Curcumin Therapy for Attaining Clinical Remission in Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Maria G. Grammatikopoulou et al.
NUTRIENTS (2018)
Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases
Ajaikumar B. Kunnumakkara et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Mesalamine Enemas for Induction of Remission in Oral Mesalamine-refractory Pediatric Ulcerative Colitis: A Prospective Cohort Study
Arie Levine et al.
JOURNAL OF CROHNS & COLITIS (2017)
Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders
Fernando Magro et al.
JOURNAL OF CROHNS & COLITIS (2017)
Pharmacokinetic interactions of curcuminoids with conventional drugs: A review
Roodabeh Bahramsoltani et al.
JOURNAL OF ETHNOPHARMACOLOGY (2017)
TGF-β in inflammatory bowel disease: a key regulator of immune cells, epithelium, and the intestinal microbiota
Sozaburo Ihara et al.
JOURNAL OF GASTROENTEROLOGY (2017)
The Essential Medicinal Chemistry of Curcumin
Kathryn M. Nelson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
A Novel Highly Bioavailable Curcumin Formulation Improves Symptoms and Diagnostic Indicators in Rheumatoid Arthritis Patients: A Randomized, Double-Blind, Placebo-Controlled, Two-Dose, Three-Arm, and Parallel-Group Study
Augustine Amalraj et al.
JOURNAL OF MEDICINAL FOOD (2017)
Comparative Oral Absorption of Curcumin in a Natural Turmeric Matrix with Two Other Curcumin Formulations: An Open-label Parallel-arm Study
Sreeraj Gopi et al.
PHYTOTHERAPY RESEARCH (2017)
Phytosomal curcumin: A review of pharmacokinetic, experimental and clinical studies
Hamed Mirzaei et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Curcuminoids modify lipid profile in type 2 diabetes mellitus: A randomized controlled trial
Yunes Panahi et al.
COMPLEMENTARY THERAPIES IN MEDICINE (2017)
Nanoencapsulation, an efficient and promising approach to maximize wound healing efficacy of curcumin: A review of new trends and state-of-the-art
Zahid Hussain et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2017)
Curcumin as a therapeutic agent in the chemoprevention of inflammatory bowel disease
Remya Sreedhar et al.
DRUG DISCOVERY TODAY (2016)
Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis
Franck Carbonnel et al.
GASTROENTEROLOGY (2016)
PRESS Peer Review of Electronic Search Strategies: 2015 Guideline Statement
Jessie McGowan et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2016)
Curcumin downregulates human tumor necrosis factor-α levels: A systematic review and meta-analysis ofrandomized controlled trials
Amirhossein Sahebkar et al.
PHARMACOLOGICAL RESEARCH (2016)
Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo-controlled Trial
Sepideh Rahmani et al.
PHYTOTHERAPY RESEARCH (2016)
Curcumin in Combination With Mesalamine Induces Remission in Patients With Mild-to-Moderate Ulcerative Colitis in a Randomized Controlled Trial
Alon Lang et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Methodology guideline for clinical studies investigating traditional Chinese medicine and integrative medicine Executive summary
Jian-Ping Liu et al.
COMPLEMENTARY THERAPIES IN MEDICINE (2015)
Clinical efficacy of the co-administration of Turmeric and Black seeds (Kalongi) in metabolic syndrome - A double blind randomized controlled trial - TAK-MetS trial
F. Amin et al.
COMPLEMENTARY THERAPIES IN MEDICINE (2015)
The beneficial role of curcumin on inflammation; diabetes and neurodegenerative disease: A recent update
Shatadal Ghosh et al.
FOOD AND CHEMICAL TOXICOLOGY (2015)
Degradation of Curcumin: From Mechanism to Biological Implications
Claus Schneider et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2015)
Curcumin, a component of golden spice: From bedside to bench and back
Sandeo Prasad et al.
BIOTECHNOLOGY ADVANCES (2014)
Induction with NCB-02 (curcumin) enema for mild-to-moderate distal ulcerative colitis - A randomized, placebo-controlled, pilot study
Vikas Singla et al.
JOURNAL OF CROHNS & COLITIS (2014)
The Chemistry of Curcumin: From Extraction to Therapeutic Agent
Kavirayani Indira Priyadarsini
MOLECULES (2014)
Cytokines in inflammatory bowel disease
Markus F. Neurath
NATURE REVIEWS IMMUNOLOGY (2014)
Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials
Subash C. Gupta et al.
AAPS JOURNAL (2013)
Curcumin ameliorates dextran sulfate sodium-induced experimental colitis by blocking STAT3 signaling pathway
Liu Liu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2013)
Curcumin inhibits interferon-gamma signaling in colonic epithelial cells
Monica T. Midura-Kiela et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)
Once-Daily Dosing of Delayed-Release Oral Mesalamine (400-mg Tablet) Is as Effective as Twice-Daily Dosing for Maintenance of Remission of Ulcerative Colitis
William J. Sandborn et al.
GASTROENTEROLOGY (2010)
Bioavailability of curcumin: Problems and promises
Preetha Anand et al.
MOLECULAR PHARMACEUTICS (2007)
Gastroenterology 2 - Inflammatory bowel disease: clinical aspects and established and evolving therapies
Daniel C. Baumgart et al.
LANCET (2007)
Curcumin maintenance therapy for ulcerative colitis: Randomized, multicenter, double-blind, placebo-controlled trial
Hiroyuki Hanai et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Novel pathophysiological concepts of inflammatory bowel disease
T Hibi et al.
JOURNAL OF GASTROENTEROLOGY (2006)
Inflammatory bowel disease: Epidemiology, pathogenesis, and therapeutic opportunities
SB Hanauer
INFLAMMATORY BOWEL DISEASES (2006)
Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study
P Marteau et al.
GUT (2005)
Medical therapy for ulcerative colitis 2004
SB Hanauer
GASTROENTEROLOGY (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Curcumin, the major component of food flavour turmeric, reduces mucosal injury in trinitrobenzene sulphonic acid-induced colitis
A Ukil et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Share Paper
